High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V.
about
Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitorsKIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on MastocytosisGermline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosisAcute Myeloid Leukemia With Inv(16)(p13q22) Associated With Hidden Systemic Mastocytosis: Case Report and Review of LiteratureCore-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy.Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-β in acute myeloid leukemiaThe serum tryptase test: an emerging robust biomarker in clinical hematology.International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis.Aberrant T helper 17 cells and related cytokines in bone marrow microenvironment of patients with acute myeloid leukemia.Mast cell adenosine receptors function: a focus on the a3 adenosine receptor and inflammation.Diagnosis, progression patterns and prognostication in mastocytosis.Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics.Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology.Modelling of a genetically diverse evolution of Systemic Mastocytosis with Chronic Myelomonocytic Leukemia (SM-CMML) by Next Generation Sequencing.Significance of mastocytemia in cats.Shared clonal cytogenetic abnormalities in aberrant mast cells and leukemic myeloid blasts detected by single nucleotide polymorphism microarray-based whole-genome scanning.Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia.
P2860
Q24306212-DCA10482-A532-48BF-9B81-128C7B5075F4Q26830207-4A976C25-2010-47A7-9D0C-AAE0C48B166BQ28080034-4C4DE78B-C704-4AEA-8175-C00E5A2A828CQ33670596-D4E0BD8F-0763-4253-924B-BA67E94C5E7BQ34663691-D0D5596F-3050-40E1-90E0-E513B245362AQ34664111-40FF0BC0-78D9-419C-AE56-29DFE857928DQ36075913-DD4C8B25-784D-41F5-B0D7-0B248BF5EDDEQ36154674-701361A2-579C-4F6F-80C7-F3817F286563Q36730397-AAE9EA7C-BA46-4CBD-96B7-4A186503B53AQ37137554-321FF947-4C9D-462E-9A0D-162690E7DF8DQ38016856-C10C4D87-5E21-4691-ABF1-8E03464E677AQ38025156-B71E058C-068D-4893-A54E-8A8BB912641AQ38041575-453B5E39-7998-46E1-858C-024B19B63632Q39779573-CFEFB9B8-73E0-4F64-AA50-943ECDFC59F9Q42737724-0F3EC34D-7054-4020-AA66-AB499B273C11Q44307733-977E5B6D-D96C-4216-9F2B-8785EB6E7173Q52885281-5275DF9A-4C50-48DB-B8CF-2DC54DC5ADB0Q54335310-39854670-4FCC-4685-A4BC-BE70B092D891
P2860
High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
High frequency of concomitant ...... ansforming KIT mutation D816V.
@en
type
label
High frequency of concomitant ...... ansforming KIT mutation D816V.
@en
prefLabel
High frequency of concomitant ...... ansforming KIT mutation D816V.
@en
P2093
P2860
P1433
P1476
High frequency of concomitant ...... ransforming KIT mutation D816V
@en
P2093
Andrea Huber
Karl Sotlar
Manuela Födinger
Marika Fritz
Robert Fritsche-Polanz
Wolfgang R Sperr
P2860
P304
P356
10.1016/J.MOLONC.2010.04.008
P577
2010-04-24T00:00:00Z